BioLamina AB

BioLamina AB is a Swedish biotech company founded on scientific innovations at Karolinska Institutet. Our main products are recombinant laminins, human proteins used to maintain and expand pluripotent stem cells and other primary cell types for subsequent differentiation into specialized cell types. BioLamina is revolutionizing cell culture, and our products are used by researchers worldwide to develop cellular therapies and contribute to the era of regenerative medicine. Established in 2009, we currently have around 70 employees who develop, produce, market, and sell cell culture research reagents to academic and industrial scientists worldwide.